Publications
- Tissue-type plasminogen activator (tPA) and its I-inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis1998 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis1997 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Tissue-type plasminogen activator (tPA) and its inhibitor (OAI-1) in CAPD1995 | Central Library of Charles University, Faculty of Medicine in Pilsen
- The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols - a comparison of thrombogenicity parameters2007 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols - a comparison of thrombogenicity parameters2007 | Faculty of Medicine in Pilsen
- The effect of regional citrate anticoagulation (RCA) on thrombogenicity and biocompatibility during CVVHDF2006 | Faculty of Medicine in Pilsen
- Tissue factor, its inhibitor, and the thrombogenicity of two new synthetic membranes2005 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Research into renal replacement therapy at the medical school in Pilsen 1999-20042005 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Plasma concentrations of von Willebrand factor in peritoneal dialysis patients2004 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Plasma concentrations of von Willebrand factor in peritoneal dialysis patients2004 | Faculty of Medicine in Pilsen, First Faculty of Medicine
Loading network view...